<html><head></head><body style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><span id="OLK_SRC_BODY_SECTION"><div><div style="color: rgb(0, 0, 0); word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "><div><p class="MsoNormal" align="center" style="font-family: Calibri, sans-serif; font-size: 14px; text-align: center; "><b style="mso-bidi-font-weight:
normal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:20.0pt;font-family:Calibri;mso-bidi-font-family:Arial">When will
patients benefit from stem cell therapy in Australia?<br></span></i></b><b style="mso-bidi-font-weight:normal"><i style="mso-bidi-font-style:
normal"><span lang="EN-US" style="font-size:16.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">- The challenges of taking stem cells from the lab
to the clinic - <o:p></o:p></span></i></b></p><p class="MsoNormal" align="center" style="font-family: Calibri, sans-serif; font-size: 14px; text-align: center; "><span class="Apple-style-span" style="font-family: Calibri; font-size: medium; "><img src="cid:7880150B-E893-4A62-A31A-C62CFCC5E3D4" type="image/png"></span><b style="mso-bidi-font-weight:
normal"><i style="mso-bidi-font-style:normal"><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;mso-bidi-font-family:Arial"><span style="mso-spacerun:yes"> </span><o:p></o:p></span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><b style="mso-bidi-font-weight:normal"><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;mso-bidi-font-family:Arial">SYDNEY,
AUSTRALIA, Tuesday 26 November 2013 –</span></b><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;mso-bidi-font-family:Arial"> Australian
stem cell experts are joining forces to address the future of stem cell research
in Australia and the critical gap in taking innovative stem cell therapies from
the laboratory to patients in the clinic. <o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial"><br>
Over 100 clinicians, scientists, policy makers, investors, IP lawyers, patient
advocates, pharma and biotech executives are participating in the Workshop - <i style="mso-bidi-font-style:normal">Innovating the Marketplace with Stem<b style="mso-bidi-font-weight:normal"> </b>Cells </i>- hosted by the NSW Stem
Cell Network to take a serious look at this vital issue facing Australia’s stem
cell industry.</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">Professor Bernie Tuch, Founder and Director of the
NSW Stem Cell Network said that Australia is the birth place of innovative
ideas in stem cell research and therapies and has demonstrated commercial
success as the birthplace of the world’s biggest stem cell company, Mesoblast
(ASX:MSB) and world leading IVF clinic Genea. Clinically we also have some of
the most innovative research including success in clinical trials for stem cell
treatment of a corneal eye disease at University of NSW and for treatment
resistant Crohn’s disease at the University of Western Australia.</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">In light of these successes, the Australian
industry is plagued by a loss of our IP, talent and manufacture to countries
abroad, that are better supported with commercialisation and investment
opportunities.<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial"><o:p> </o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">‘A collective effort is needed to push this
industry forward. Basic researchers need to become educated as to the part they
play in getting their technology to patients and interactions need to improve
between Australia’s researchers, clinicians, commercial and regulatory bodies
towards driving realistic solutions.’<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial"><o:p> </o:p></span></p><p class="MsoPlainText" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="X-NONE" style="font-size:11.0pt;font-family:
Calibri;mso-bidi-font-family:Calibri">‘</span><span style="font-size:11.0pt;
font-family:Calibri;mso-bidi-font-family:Calibri;mso-ansi-language:EN-AU">The
US, Switzerland, Germany, the UK, many countries are currently running clinical
trials for which we have the expertise in Australia, many even utilise
Australian technologies. We cannot miss the chance to lead this industry by sitting
back and waiting</span><span lang="X-NONE" style="font-size:11.0pt;font-family:
Calibri;mso-bidi-font-family:Calibri">’, said Professor Tuch.<o:p></o:p></span></p><h1 align="left" style="font-family: Calibri, sans-serif; font-size: 14px; text-align: left; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;font-weight:normal;mso-bidi-font-weight:bold"><o:p> </o:p></span></h1><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">Key-note speaker, Professor Igor Slukvin,
University Wisconsin-Madison will be presenting a new stem cell technology, Cymerus<sup>TM</sup>,
which has the potential to manufacture billions of human Mesenchymal stem cells
from a single embryonic stem cell and poses great therapeutic for patients.<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial"><span style="mso-spacerun:yes"> </span><o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">Dr Slukvin invented his technology in Wisconsinlaboratory alongside Professor James Thomson, who is well-known for creating
the world’s first embryonic stem (ES) cell line in 1998 and human induced
pluripotent stem cells in 2007.<span style="mso-spacerun:yes">  </span><o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial"><o:p> </o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">“Stem cell therapy has not taken the path that
scientists predicted over ten years ago. We have found only one type of stem
cell, The <span style="mso-spacerun:yes"> </span>Mesenchymal stem cell show
great promise and is ready for clinical trial for a broad range of diseasesright now,” says Dr Slukvin. <o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial"><o:p> </o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">Mesenchymal stem cells works by stimulating thebody’s own healing systems and have the potential to remedy a broad range of
diseases including cardiovascular disease, diabetes, diseases of the blood,lung, kidney, eyes teeth and immune system diseases.<o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial"><o:p> </o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri;
mso-bidi-font-family:Arial">Dr Paul Brock who has Motor Neurone Disease and is
a long time advocate of stem cell technologies in Australia </span><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri">says, “I have been
disappointed at what has appeared to me to have been the slow take up of
Australian research projects utilising the legislative green light given toembryonic stem cell research and somatic cell nuclear transfer research by
those Bills.” <o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri"><o:p> </o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri">However
he is ‘confident that effectively resourced, internationally collaborative stem
cell research, thriving within a multidisciplinary cross-siloed scientific
approach to ultimately producing successful therapeutic outcomes, will play a
vital role in better understanding the causes of and eventually developing
cures for currently incurable, terminal neurological diseases such as MotorNeurone Disease’ </span><span lang="EN-US" style="font-size:11.0pt;font-family:
Calibri;mso-bidi-font-family:Arial"><o:p></o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri"><o:p> </o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Calibri">Recent
activity in Australian stem cell research and industry indicates that if
properly supported this slow up take is about to change.</span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="EN-US" style="font-size:11.0pt;font-family:Arial"><o:p> </o:p></span></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; text-align: justify; "><b><span lang="EN-US" style="font-size:11.0pt;font-family:Arial;text-transform:uppercase">Media
INVITATION</span></b><b><span lang="EN-US" style="font-size:11.0pt;font-family:Arial;text-transform:uppercase"><o:p> </o:p></span></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; "><b style="mso-bidi-font-weight:normal"><span style="font-size:11.0pt;font-family:Calibri;mso-fareast-font-family:Calibri;
mso-bidi-font-family:Arial;mso-ansi-language:EN-AU;mso-fareast-language:EN-AU">RSVP: Daniella
Goldberg </span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:10.0pt;font-family:Calibri;mso-fareast-font-family:Calibri;
mso-bidi-font-family:Arial;mso-ansi-language:EN-AU;mso-fareast-language:EN-AU">PhD</span></b><b style="mso-bidi-font-weight:normal"><span style="font-size:11.0pt;font-family:
Calibri;mso-fareast-font-family:Calibri;mso-bidi-font-family:Arial;mso-ansi-language:
EN-AU;mso-fareast-language:EN-AU">, Gene Genie Media: Tel: 0416 211 067 eml:
<a href="mailto:Daniella@genegeniemedia.com.au">Daniella@genegeniemedia.com.au</a></span></b><span style="font-size:11.0pt;
font-family:Calibri;mso-fareast-font-family:Calibri;mso-bidi-font-family:Arial;
mso-ansi-language:EN-AU;mso-fareast-language:EN-AU"><o:p></o:p></span></p><p class="MsoBodyText" align="left" style="text-align: left; "><span lang="X-NONE"><span id="OLK_SRC_BODY_SECTION" style="font-size: 14px; font-weight: normal; font-family: Calibri, sans-serif; "><div><div style="color: rgb(0, 0, 0); font-family: Calibri, sans-serif; word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "><div><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><div style="font-family: Calibri, sans-serif; font-size: 14px; "><p class="MsoNormal"><b><i><span lang="EN-US" style="font-size: 11pt; font-family: Calibri; ">Event:  Stem Cell Workshop – Innovating the Marketplace with Stem Cells</span></i></b></p></div></div></div></span></div></div></div></span><span id="OLK_SRC_BODY_SECTION"><div><div style="color: rgb(0, 0, 0); word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; "><div><span id="OLK_SRC_BODY_SECTION"><div><div style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space; color: rgb(0, 0, 0); "><div><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; font-weight: normal; "><b><i><span lang="EN-US" style="font-size: 11pt; font-family: Calibri; ">Time: <span class="Apple-tab-span" style="white-space: pre; "> </span>830am  - 7pm</span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; font-weight: normal; "><b><i><span lang="EN-US" style="font-size: 11pt; font-family: Calibri; ">Date: <span class="Apple-tab-span" style="white-space: pre; ">   </span>Friday 29 November </span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; font-weight: normal; "><b><i><span lang="EN-US" style="font-size: 11pt; font-family: Calibri; ">Venue:<span class="Apple-tab-span" style="white-space: pre; "> </span>Convention Centre, Darling Harbour, Sydney<o:p></o:p></span></i></b></p><p class="MsoNormal" style="font-family: Calibri, sans-serif; font-size: 14px; font-weight: normal; "><span class="Apple-style-span" style="font-size: 15px; font-family: Calibri; "><b>Stem Cell Workshop Program and registration:</b> <a href="http://www.stemcellnetwork.org.au/Workshop/MainFrameSet.html">http://www.stemcellnetwork.org.au/Workshop/MainFrameSet.html</a></span></p><div style="font-family: Calibri, sans-serif; font-size: 14px; font-weight: normal; "><br></div></div></div></div></span></div></div></div></span><!--[if !supportLineBreakNewLine]--><br style="mso-special-character:line-break"><!--[endif]--></span><span lang="X-NONE" style="font-size: 11pt; font-weight: normal; font-family: Calibri, sans-serif; "><o:p></o:p></span></p><p class="MsoBodyText" style="font-family: Calibri, sans-serif; font-size: 14px; "><span lang="X-NONE" style="font-size:11.0pt"><o:p> </o:p></span></p><!--EndFragment--></div></div></div></span></div></div></span></div></div></span></div></div></span></div></div></span></div></div></span></div></div></span></body></html>